首页 › 基金 › Rangeley Capital, LLC › ABUS

Rangeley Capital, LLC 对 ABUS 的持仓历史

ARBUTUS BIOPHARMA CORP · 医疗保健

Rangeley Capital, LLC 在 Q2 2026 的 13F 申报中披露持有 ABUS(ARBUTUS BIOPHARMA CORP)500,000 股,市值约 US$2.4M,约占其申报组合的 2.29%,在其申报持仓中市值排名第 8 位。 Rangeley Capital, LLC 最近 7 个申报季度中有 7 个季度披露了 ABUS 持仓,最早可追溯至 Q4 2024。

最新持仓 (Q2 2026)500.00K 股
申报持仓市值$2.40M
组合权重2.29%
首次申报Q4 2024
最近变动持有
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Rangeley Capital, LLC 对 ABUS 的持仓演变

Rangeley Capital, LLC 于 Q4 2024 首次披露 ABUS 持仓:1,459,000 股(约 US$4.8M)。 在 7 次申报中,Rangeley Capital, LLC 0 次增持、4 次减持、2 次保持不变。 最近一期申报(Q2 2026)显示持股 500,000 股、市值约 US$2.4M。 持仓曾出现大幅变动:Q2 2025 减持约 36% (随后一个季度股价上涨 47%)、Q1 2026 减持约 40% (随后一个季度股价上涨 7%)。

逐季持仓明细

季度股数金额变化
Q4 2024 1.46M $4.77M 新进
Q1 2025 1.35M $4.71M 减持
Q2 2025 865.00K $2.67M 减持
Q3 2025 840.00K $3.81M 减持
Q4 2025 840.00K $4.04M 持有
Q1 2026 500.00K $2.25M 减持
Q2 2026 500.00K $2.40M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ABUS 与 13F 数据

ABUS(ARBUTUS BIOPHARMA CORP)属于医疗保健行业。我们追踪的基金中还有 43 只申报持有 ABUS,申报仓位最大的包括:Whitefort Capital Management, LP (US$75.8M), Two Seas Capital LP (US$38.9M), BlackBarn Capital Partners LP (US$12.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ABUS 的基金

查看 ABUS 的全部基金持有人 →

常见问题

How long has Rangeley Capital, LLC held ABUS?

Rangeley Capital, LLC has disclosed ABUS holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Rangeley Capital, LLC's current position in ABUS?

As of Q2 2026, Rangeley Capital, LLC holds 500.00K shares of ABUS (ARBUTUS BIOPHARMA CORP), valued at $2.40M, representing 2.29% of its reported portfolio and ranking #8.

Has Rangeley Capital, LLC been buying or selling ABUS?

In the latest 13F filing (Q2 2026), Rangeley Capital, LLC held unchanged its position in ABUS.

Which other funds hold ABUS?

Other major institutional holders of ABUS include Whitefort Capital Management, LP, Two Seas Capital LP, BlackBarn Capital Partners LP, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.